NCT07648940 Bioequivalence Study of Liposomal Doxorubicin 20 mg/10 mL (Doxopeg® vs Caelyx®) in Advanced Cancer Patients Status COMPLETED Phase PHASE1
NCT06997029 A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT04862325 SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERAS Status COMPLETED Phase NA
NCT03737643 Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE3